Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark
暂无分享,去创建一个
[1] Thomas A. Louis,et al. Nonparametric estimation of the joint distribution of survival time and mark variables , 1998 .
[2] Peter B. Gilbert,et al. Inferences on relative failure rates in stratified mark‐specific proportional hazards models with missing marks, with application to human immunodeficiency virus vaccine efficacy trials , 2015 .
[3] Mei Li,et al. Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials. , 2013, Biostatistics.
[4] John D. Kalbfleisch,et al. Misspecified proportional hazard models , 1986 .
[5] Jerome H. Kim,et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.
[6] Subhash R. Lele,et al. Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials , 1999 .
[7] Erhard Cramer,et al. Progressively Type-II censored competing risks data from Lomax distributions , 2011, Comput. Stat. Data Anal..
[8] L. J. Wei,et al. The Robust Inference for the Cox Proportional Hazards Model , 1989 .
[9] Haoxuan Zhou,et al. Failure time regression with continuous covariates measured with error , 2000 .
[10] David Heckerman,et al. Leveraging Information Across HLA Alleles/Supertypes Improves Epitope Prediction , 2007, J. Comput. Biol..
[11] Donghoon Han,et al. Inference for a simple step-stress model with competing risks for failure from the exponential distribution under time constraint , 2010, Comput. Stat. Data Anal..
[12] Ren Johansen. An Empirical Transition Matrix for Non-homogeneous Markov Chains Based on Censored Observations , 1978 .
[13] R. Hashemi,et al. Analysis of dependent competing risks in the presence of progressive hybrid censoring using Marshall-Olkin bivariate Weibull distribution , 2015, Comput. Stat. Data Anal..
[14] Ian W McKeague,et al. PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKS. , 2009, Annals of statistics.
[15] S W Lagakos,et al. Properties of proportional-hazards score tests under misspecified regression models. , 1984, Biometrics.
[16] M Schumacher,et al. Statistical analysis of quality of life data in cancer clinical trials. , 1990, Statistics in medicine.
[17] Peter B Gilbert,et al. Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing Marks. , 2012, Scandinavian journal of statistics, theory and applications.
[18] Peter B. Gilbert,et al. Tests for Comparing Mark-Specific Hazards and Cumulative Incidence Functions , 2004, Lifetime data analysis.
[19] S Brunak,et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. , 2003, Tissue antigens.
[20] Hulin Wu,et al. Semiparametric Time‐Varying Coefficients Regression Model for Longitudinal Data , 2005 .
[21] Devan V Mehrotra,et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.
[22] Ian W McKeague,et al. The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy. , 2007, Biostatistics.
[23] S W Lagakos,et al. Effects of mismodelling and mismeasuring explanatory variables on tests of their association with a response variable. , 1988, Statistics in medicine.
[24] Z. Ying,et al. Checking the Cox model with cumulative sums of martingale-based residuals , 1993 .